Atria Wealth Solutions Inc. Raises Stock Holdings in CME Group Inc. (NASDAQ:CME)

Key Points

• Atria Wealth Solutions Inc. increased its stake in CME Group Inc. by 40.5% in the first quarter, owning a total of 6,060 shares valued at approximately $1.6 million.
• Other hedge funds also boosted their positions, with Bank Pictet & Cie Europe AG raising its holdings by 29.0%, now owning 86,941 shares valued at around $20.2 million.
• CME Group reported earnings of $2.96 per share for the last quarter, exceeding analysts' expectations and marking a 10.4% revenue increase compared to the previous year.

Atria Wealth Solutions Inc. raised its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 40.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,060 shares of the financial services provider's stock after acquiring an additional 1,746 shares during the period. Atria Wealth Solutions Inc.'s holdings in CME Group were worth $1,608,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also modified their holdings of the company. Bank Pictet & Cie Europe AG raised its holdings in CME Group by 29.0% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 86,941 shares of the financial services provider's stock valued at $20,190,000 after buying an additional 19,533 shares during the period. Advisory Services Network LLC raised its holdings in CME Group by 15.5% during the 4th quarter. Advisory Services Network LLC now owns 1,609 shares of the financial services provider's stock valued at $374,000 after buying an additional 216 shares during the period. Jaffetilchin Investment Partners LLC raised its holdings in CME Group by 13.9% during the 4th quarter. Jaffetilchin Investment Partners LLC now owns 2,937 shares of the financial services provider's stock valued at $682,000 after buying an additional 359 shares during the period. Heritage Trust Co purchased a new stake in CME Group during the 4th quarter valued at $303,000. Finally, Crux Wealth Advisors purchased a new stake in CME Group during the 4th quarter valued at $1,011,000. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Price Performance

CME opened at $282.21 on Friday. CME Group Inc. has a 12-month low of $203.77 and a 12-month high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The business's fifty day simple moving average is $275.84 and its 200-day simple moving average is $265.90. The company has a market capitalization of $101.70 billion, a price-to-earnings ratio of 27.32, a PEG ratio of 5.01 and a beta of 0.44.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%. The business had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter in the prior year, the company earned $2.56 EPS. The business's revenue was up 10.4% compared to the same quarter last year. On average, equities research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Tuesday, September 9th will be paid a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. CME Group's dividend payout ratio (DPR) is currently 48.40%.

Analyst Ratings Changes

Several analysts recently weighed in on the company. UBS Group restated a "neutral" rating and set a $305.00 price target on shares of CME Group in a report on Thursday, July 24th. Keefe, Bruyette & Woods increased their price target on CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a report on Thursday, April 24th. Erste Group Bank lowered CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Wall Street Zen lowered CME Group from a "hold" rating to a "sell" rating in a report on Sunday, July 13th. Finally, JPMorgan Chase & Co. reduced their target price on CME Group from $223.00 to $211.00 and set an "underweight" rating on the stock in a research note on Thursday, April 24th. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $261.93.

Insider Activity

In related news, General Counsel Jonathan L. Marcus sold 390 shares of the company's stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $277.50, for a total transaction of $108,225.00. Following the completion of the sale, the general counsel directly owned 6,708 shares in the company, valued at $1,861,470. This represents a 5.49% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Charles P. Carey sold 500 shares of the company's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total value of $132,675.00. Following the sale, the director owned 4,900 shares of the company's stock, valued at $1,300,215. This trade represents a 9.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 5,750 shares of company stock worth $1,576,294 over the last ninety days. 0.30% of the stock is currently owned by corporate insiders.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.